Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > BUSINESS
BUSINESS
- Lilly and BI in Long-term Collaboration; AZ and BMS Expanding Product Lineup
January 7, 2013
- Kowa Acquires 2 Major Products for “Post-Livalo” Era; How to Avoid Competition between Partners Holds Key in Comarketing
January 7, 2013
- Kyowa Kirin to Enhance Nephrology Lineup with DPP-4 Inhibitor; Companies Aiming to Capture Market through “2-Sword” Strategy
January 7, 2013
- Yoshindo, Ajinomoto Pharmaceuticals to Establish Joint Venture in Infusion and Dialysis Business
December 28, 2012
- Kissei Submits Application for Additional Indications for Combination Therapy of Glufast and DPP-4 Inhibitor or Biguanide
December 28, 2012
- Takeda Terminates Agreement with US Company on Anti-Obesity Drug Development
December 27, 2012
- Mitsubishi Chemical HD to Acquire Qualicaps
December 27, 2012
- Otsuka, Lundbeck File MAA for Abilify Once-Monthly Formulation with EMA
December 27, 2012
- Janssen Pharmaceutical Files for Additional Indication of Chronic Pain for OneDuro Patch
December 26, 2012
- Terumo Forms Alliance with AngioCare of China for Renal Denervation Catheter
December 26, 2012
- Takeda to Establish Global Customer Market Business Insights Department
December 26, 2012
- Takeda Voluntarily Recalls Ethical Version of Alinamin-F5 Injection
December 26, 2012
- Immunotherapeutic Cancer Drug Fails to Meet Primary Endpoint in PIII Study: Merck Serono
December 25, 2012
- Mortality Rate of Patients After Major Bleeds Significantly Lower with Dabigatran: BI
December 25, 2012
- Safety of Xarelto Found to Be “Consistent with Clinical Trial Data” in EPPV: Bayer Yakuhin
December 25, 2012
- Generic-only Companies Which Rely on Wholesales Worried About Decline in Their Relative Position with Wholesalers
December 25, 2012
- Increasing Competition in AD Drug Market; Sales of Over 240 Billion Yen Predicted by 2020
December 25, 2012
- Novartis Files for Approval of Combination Drug of Rasilez, CCB
December 21, 2012
- Nexium Dominates No.1, 2 Ranking in HP Market for 3rd Consecutive Month: Rep Track Survey
December 21, 2012
- Bayer Files for Approval of Radioactive Anticancer Agent in US and Europe
December 20, 2012
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…